Market revenue in 2024 | USD 22.3 million |
Market revenue in 2030 | USD 40.7 million |
Growth rate | 10.7% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 71.3% in 2024. Horizon Databook has segmented the Italy deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Italy deep brain stimulation devices market is anticipated to exhibit consistent growth rate of 10.2% over the forecast period due to growing prevalence of neurological diseases and increasing research activities for the development of new deep brain stimulation devices.
For instance, in July 2017, a spinoff company of University of Milan developed and patented a new deep brain stimulation device for the treatment of PD. Moreover, increasing incidence of epilepsy and OCD is a major factor driving this market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account